"The US Food and Drug Administration (FDA) has approved the long-acting muscarinic antagonist tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim) for long-term maintenance treatment of asthma in people aged 12 years and older, accor"...
Patients being treated with FLOVENT (fluticasone propionate) Inhalation Aerosol should receive the following information and instructions. This information is intended to aid them in the safe and effective use of this medication. It is not a disclosure of all possible adverse or intended effects.
Patients should use FLOVENT (fluticasone propionate) Inhalation Aerosol at regular intervals as directed. Results of clinical trials indicated significant improvement may occur within the first day or two of treatment; however, the full benefit may not be achieved until treatment has been administered for 1 to 2 weeks or longer. The patient should not increase the prescribed dosage but should contact the physician if symptoms do not improve or if the condition worsens.
After inhalation, rinse the mouth with water without swallowing.
For the proper use of FLOVENT (fluticasone propionate) Inhalation Aerosol and to attain maximum improvement, the patient should read and follow carefully the Patient s Instructions for Use accompanying the product.
Last reviewed on RxList: 12/30/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Flovent Information
Flovent - User Reviews
Flovent User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.